Corcept Therapeutics Incorporated (CORT)

Corcept Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	128.59	135.55	66.33	77.62	76.19	31.27
Short-Term Investments	344.57	232.67	365.34	145.92	364.51	244.69
Cash & Short-Term Investments	473.16	368.22	431.67	223.54	440.7	275.96
Cash Growth	30.25%	-14.70%	93.11%	-49.28%	59.69%	33.47%
Accounts Receivable	53.84	41.12	31.06	27.63	26.2	19.93
Other Receivables	2.3	15.7	15.8	1.4	1.3	1
Receivables	56.14	56.82	46.86	29.03	27.5	20.93
Inventory	8.35	7.73	6.1	4.99	4.91	5.42
Prepaid Expenses	5.15	25.86	14.62	8.92	5.4	5.04
Other Current Assets	18.06	-	-	-	-	-
Total Current Assets	560.85	458.64	499.25	266.46	478.5	307.36
Property, Plant & Equipment	7.16	0.32	1.78	1.52	4.18	4.5
Long-Term Investments	19.32	57.18	4.95	112.28	36.2	39.35
Long-Term Deferred Tax Assets	111.85	90.61	61.47	27.46	31.6	45.68
Other Long-Term Assets	15.39	14.79	15.99	16.05	21.25	15.43
Total Assets	714.56	621.52	583.43	423.76	571.73	412.31
Accounts Payable	19.48	17.4	11.98	6.91	10.55	7.54
Accrued Expenses	75.93	70.49	44.52	39.3	34.69	28.96
Current Portion of Leases	0.04	0.15	1.14	0.53	2.05	1.56
Current Income Taxes Payable	-	1.81	0.09	0.51	-	-
Other Current Liabilities	5.3	14.65	14.76	0.3	0.2	0.78
Total Current Liabilities	100.75	104.51	72.49	47.54	47.49	38.84
Long-Term Leases	5.63	-	-	-	0.5	1.9
Other Long-Term Liabilities	11.94	10.31	9.1	0.41	0.4	0.39
Total Liabilities	118.31	114.81	81.59	47.95	48.39	41.13
Common Stock	0.13	0.13	0.13	0.13	0.12	0.12
Additional Paid-In Capital	781.01	738.52	662.34	591.35	516.14	457.06
Retained Earnings	465.78	402.53	296.39	194.97	82.46	-23.56
Treasury Stock	-650.76	-635.08	-456.15	-410.41	-75.8	-62.7
Comprensive Income & Other	0.08	0.61	-0.87	-0.23	0.42	0.26
Shareholders' Equity	596.24	506.71	501.84	375.81	523.34	371.18
Total Liabilities & Equity	714.56	621.52	583.43	423.76	571.73	412.31
Total Debt	5.67	0.15	1.14	0.53	2.55	3.46
Net Cash (Debt)	486.8	425.25	435.48	335.29	474.34	311.85
Net Cash Growth	34.12%	-2.35%	29.88%	-29.32%	52.10%	50.83%
Net Cash Per Share	4.39	3.81	3.76	2.66	3.82	2.54
Filing Date Shares Outstanding	104.49	103.52	107.9	105.96	117.31	114.59
Total Common Shares Outstanding	104.4	103.41	107.84	105.94	116.74	114.55
Working Capital	460.1	354.13	426.76	218.92	431.01	268.52
Book Value Per Share	5.71	4.90	4.65	3.55	4.48	3.24
Tangible Book Value	596.24	506.71	501.84	375.81	523.34	371.18
Tangible Book Value Per Share	5.71	4.90	4.65	3.55	4.48	3.24
Machinery	-	-	-	1.16	0.81	0.3
Leasehold Improvements	-	-	-	1.26	1.23	0.53

Source: S&P Capital IQ. Standard template. Financial Sources.